ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

Immunoassays For Isoenzymes

April 15, 1983

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

October 2, 1992

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993